Клиническая стоматология.
Общество с ограниченной ответственностью ТБИ Компания.
Том 27.
2024.
С. 46-51
The review presents the results of the blood substitute development based on perfluororganic compounds (PFC). The limitations of PFC due to which their further development was suspended are described. The presented data allows us to imagine a possible way to create optimal drugs based on PFC. Chemically inactive perfluorocomponents should be used — perfluorinated hydrocarbons and tertiary perfluorinated amines. However, in order to emulsify and stabilize the emulsion, other types of effective and chemically indifferent surfactants that do not interact with oxygen and other components of the drug are needed. © Springer Science+Business Media, LLC, part of Springer Nature 2024.